Related Experiment Video

Updated: May 11, 2026

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
09:52

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii

Published on: July 12, 2013

Protein kinases of Toxoplasma gondii: functions and drug targets

Feng Wei1, Wei Wang, Quan Liu

  • 1College of Life Science, Jilin Agricultural University, 2888 Xincheng Street, Changchun, 130118, People's Republic of China.

Parasitology Research
|May 18, 2013
PubMed

Insights

Toxoplasma gondii protein kinases are vital for parasite survival and represent promising drug targets. Inhibitors targeting these unique kinases offer a potential new strategy for treating toxoplasmosis.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Drug Discovery

Background:

  • Toxoplasma gondii is an opportunistic parasite causing severe diseases, particularly in immunocompromised individuals.
  • Current treatments for toxoplasmosis are toxic and ineffective, with no available vaccine.
  • Protein kinases (PKs) are essential for T. gondii's life cycle and pathogenesis.

Purpose of the Study:

  • To review the functions of T. gondii protein kinases.
  • To explore T. gondii PKs as potential drug targets for treating toxoplasmosis.
  • To discuss inhibitors of T. gondii PKs as therapeutic agents.

Main Methods:

  • Literature review of T. gondii protein kinase functions.
  • Analysis of T. gondii-specific PKs as drug targets.
  • Discussion of existing and potential PK inhibitors.

Main Results:

  • T. gondii PKs regulate critical processes including cell invasion, stress response, differentiation, cell cycle, and host manipulation.
  • T. gondii PKs exhibit structural and functional differences compared to mammalian PKs.
  • Rhoptry kinases are T. gondii-specific and involved in host cell invasion.

Conclusions:

  • T. gondii protein kinases are essential for parasite survival and virulence.
  • The unique nature of T. gondii PKs makes them attractive targets for novel drug development.
  • Inhibitors targeting these PKs hold promise for developing safer and more effective treatments for toxoplasmosis.

More Related Videos

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii11:37

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Published on: June 22, 2017

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...